Jon P. Stonehouse
Director
Common Stock
- Value context
- $6.25K
- Reported price
- $9.70 / share
BIOCRYST PHARMACEUTICALS INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockGrant or award | 644$9.70 / share | $6.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,288$9.70 / share | $12.49K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,159$9.70 / share | $11.24K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 644$9.70 / share | $6.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,288$9.70 / share | $12.49K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
Showing the latest 20 of 34 trades. Show all 34 trades
BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member